Hospira ‘biosimilar’ anemia drug heads for U.S. testing

Published August 2, 2010

Hospira ‘biosimilar’ anemia drug heads for U.S. testing
In the wake of health reform’s passage, Hospira Inc. will begin testing an experimental cheaper version of a popular anemia treatment in the first phase of a U.S. clinical trial.
Read more on Chicago Tribune

Thermo Fisher to Collaborate with Japanese Researchers on Tokyo-Based Biomarker Research Center
Thermo Fisher announced this week a collaboration with researchers at the Tokyo Medical University Hospital to establish a new Biomarker Research Center in Tokyo.
Read more on GenomeWeb News

Nuvo Research announces 2010 second quarter financial results
Nuvo Research Inc. , a drug development company focused on the research and development of drug products that are delivered into and through the skin using its topical and transdermal drug delivery technologies, and on the development of its immune modulating drug candidate WF10, today announced its financial and operational results for the quarter ended June 30, 2010.
Read more on PR Newswire via Yahoo! Finance